Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core

Yuko Okamoto, Kazuaki Taguchi, Keishi Yamasaki, Mina Sakuragi, Shun'ichi Kuroda, Masaki Otagiri

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Liposomes are clinically used in drug delivery, but loading hydrophobic substances is limited to the hydrophobic space of a lipid membrane, despite the fact that it is favorable to encapsulate substances into the inner aqueous core of liposome, from a drug stability of view. We report herein on the preparation of a liposome with bovine serum albumin encapsulated (BSA-liposome). Using this system, it is possible to encapsulate hydrophobic drugs in the inner aqueous core of the liposome based on the hypothesis that the water solubility of hydrophobic drugs is increased when bound to albumin. The physicochemical properties of the prepared BSA-liposomes could be easily regulated and the loading of hydrophobic drugs in the inner aqueous core of the liposome was dramatically improved by virtue of the drug-binding properties of albumin. An in vivo safety and pharmacokinetic study showed that BSA-liposomes possess favorable properties as a drug carrier, including biocompatibility and a stealth effect. This new type of hydrophobic drug carrier, an albumin-liposome, has the potential for use in delivering numerous hydrophobic drugs that typically bind to albumin.

Original languageEnglish
Pages (from-to)436-445
Number of pages10
JournalJournal of Pharmaceutical Sciences
Volume107
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1
Externally publishedYes

Fingerprint

Drug Carriers
Liposomes
Albumins
Pharmaceutical Preparations
Drug Stability
Membrane Lipids
Bovine Serum Albumin
Solubility
Pharmacokinetics
Safety
Water

Keywords

  • albumin
  • biocompatibility
  • liposomes
  • protein binding
  • solubility

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Albumin-Encapsulated Liposomes : A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core. / Okamoto, Yuko; Taguchi, Kazuaki; Yamasaki, Keishi; Sakuragi, Mina; Kuroda, Shun'ichi; Otagiri, Masaki.

In: Journal of Pharmaceutical Sciences, Vol. 107, No. 1, 01.01.2018, p. 436-445.

Research output: Contribution to journalArticle

Okamoto, Yuko ; Taguchi, Kazuaki ; Yamasaki, Keishi ; Sakuragi, Mina ; Kuroda, Shun'ichi ; Otagiri, Masaki. / Albumin-Encapsulated Liposomes : A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core. In: Journal of Pharmaceutical Sciences. 2018 ; Vol. 107, No. 1. pp. 436-445.
@article{77fa981f222d42f881a0e09b6fbb8d1e,
title = "Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core",
abstract = "Liposomes are clinically used in drug delivery, but loading hydrophobic substances is limited to the hydrophobic space of a lipid membrane, despite the fact that it is favorable to encapsulate substances into the inner aqueous core of liposome, from a drug stability of view. We report herein on the preparation of a liposome with bovine serum albumin encapsulated (BSA-liposome). Using this system, it is possible to encapsulate hydrophobic drugs in the inner aqueous core of the liposome based on the hypothesis that the water solubility of hydrophobic drugs is increased when bound to albumin. The physicochemical properties of the prepared BSA-liposomes could be easily regulated and the loading of hydrophobic drugs in the inner aqueous core of the liposome was dramatically improved by virtue of the drug-binding properties of albumin. An in vivo safety and pharmacokinetic study showed that BSA-liposomes possess favorable properties as a drug carrier, including biocompatibility and a stealth effect. This new type of hydrophobic drug carrier, an albumin-liposome, has the potential for use in delivering numerous hydrophobic drugs that typically bind to albumin.",
keywords = "albumin, biocompatibility, liposomes, protein binding, solubility",
author = "Yuko Okamoto and Kazuaki Taguchi and Keishi Yamasaki and Mina Sakuragi and Shun'ichi Kuroda and Masaki Otagiri",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.xphs.2017.08.003",
language = "English",
volume = "107",
pages = "436--445",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Albumin-Encapsulated Liposomes

T2 - A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core

AU - Okamoto, Yuko

AU - Taguchi, Kazuaki

AU - Yamasaki, Keishi

AU - Sakuragi, Mina

AU - Kuroda, Shun'ichi

AU - Otagiri, Masaki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Liposomes are clinically used in drug delivery, but loading hydrophobic substances is limited to the hydrophobic space of a lipid membrane, despite the fact that it is favorable to encapsulate substances into the inner aqueous core of liposome, from a drug stability of view. We report herein on the preparation of a liposome with bovine serum albumin encapsulated (BSA-liposome). Using this system, it is possible to encapsulate hydrophobic drugs in the inner aqueous core of the liposome based on the hypothesis that the water solubility of hydrophobic drugs is increased when bound to albumin. The physicochemical properties of the prepared BSA-liposomes could be easily regulated and the loading of hydrophobic drugs in the inner aqueous core of the liposome was dramatically improved by virtue of the drug-binding properties of albumin. An in vivo safety and pharmacokinetic study showed that BSA-liposomes possess favorable properties as a drug carrier, including biocompatibility and a stealth effect. This new type of hydrophobic drug carrier, an albumin-liposome, has the potential for use in delivering numerous hydrophobic drugs that typically bind to albumin.

AB - Liposomes are clinically used in drug delivery, but loading hydrophobic substances is limited to the hydrophobic space of a lipid membrane, despite the fact that it is favorable to encapsulate substances into the inner aqueous core of liposome, from a drug stability of view. We report herein on the preparation of a liposome with bovine serum albumin encapsulated (BSA-liposome). Using this system, it is possible to encapsulate hydrophobic drugs in the inner aqueous core of the liposome based on the hypothesis that the water solubility of hydrophobic drugs is increased when bound to albumin. The physicochemical properties of the prepared BSA-liposomes could be easily regulated and the loading of hydrophobic drugs in the inner aqueous core of the liposome was dramatically improved by virtue of the drug-binding properties of albumin. An in vivo safety and pharmacokinetic study showed that BSA-liposomes possess favorable properties as a drug carrier, including biocompatibility and a stealth effect. This new type of hydrophobic drug carrier, an albumin-liposome, has the potential for use in delivering numerous hydrophobic drugs that typically bind to albumin.

KW - albumin

KW - biocompatibility

KW - liposomes

KW - protein binding

KW - solubility

UR - http://www.scopus.com/inward/record.url?scp=85028922322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028922322&partnerID=8YFLogxK

U2 - 10.1016/j.xphs.2017.08.003

DO - 10.1016/j.xphs.2017.08.003

M3 - Article

C2 - 28826882

AN - SCOPUS:85028922322

VL - 107

SP - 436

EP - 445

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 1

ER -